Bavaria Agrees to Buy Russia’s Covid-19 Shot Pending EU Approval
This article is for subscribers only.
Bavaria signed a preliminary agreement to secure as many as 2.5 million doses of Russia’s Sputnik V Covid-19 vaccine, some of which would be produced at a facility in the German state.
The deal with the state-run Russian Direct Investment Fund, which backed Sputnik V’s development and is in charge of its international roll-out, is contingent on the shot gaining European Union or German approval, Bavaria’s health ministry said in an emailed statement.